NEW YORK (GenomeWeb) — Immunovia and the University of Liverpool have entered into a collaboration to validate Immunovia's proteomic blood test for early detection of pancreatic cancer in a prospective clinical study.

The study, which aims to validate Immunovia's Immray PanCan-d test, will start in the second half of 2016 and run for three years across sites in the US and Europe.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.